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Abstract
Background: Self-management is essential to caring for high-need, high-cost (HNHC) populations. Advances in mobile phone
technology coupled with increased availability and adoption of health-focused mobile apps have made self-management more
achievable, but the extent and quality of the literature supporting their use is not well defined.
Objective: The purpose of this review was to assess the breadth, quality, bias, and types of outcomes measured in the literature
supporting the use of apps targeting HNHC populations.
Methods: Data sources included articles in PubMed and MEDLINE (National Center for Biotechnology Information), EMBASE
(Elsevier), the Cochrane Central Register of Controlled Trials (EBSCO), Web of Science (Thomson Reuters), and the NTIS
(National Technical Information Service) Bibliographic Database (EBSCO) published since 2008. We selected studies involving
use of patient-facing iOS or Android mobile health apps. Extraction was performed by 1 reviewer; 40 randomly selected articles
were evaluated by 2 reviewers to assess agreement.
Results: Our final analysis included 175 studies. The populations most commonly targeted by apps included patients with
obesity, physical handicaps, diabetes, older age, and dementia. Only 30.3% (53/175) of the apps studied in the reviewed literature
were identifiable and available to the public through app stores. Many of the studies were cross-sectional analyses (42.9%, 75/175),
small (median number of participants=31, interquartile range 11.0-207.2, maximum 11,690), or performed by an app’s developers
(61.1%, 107/175). Of the 175 studies, only 36 (20.6%, 36/175) studies evaluated a clinical outcome.
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.1http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Conclusions: Most apps described in the literature could not be located on the iOS or Android app stores, and existing research
does not robustly evaluate the potential of mobile apps. Whereas apps may be useful in patients with chronic conditions, data do
not support this yet. Although we had 2-3 reviewers to screen and assess abstract eligibility, only 1 reviewer abstracted the data.
This is one limitation of our study. With respect to the 40 articles (22.9%, 40/175) that were assigned to 2 reviewers (of which 3
articles were excluded), inter-rater agreement was significant on the majority of items (17 of 30) but fair-to-moderate on others.
(JMIR Mhealth Uhealth 2016;4(4):e136)   doi:10.2196/mhealth.6445
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Introduction
Caring for high-need, high-cost (HNHC) populations represents
a complex problem because these individuals often suffer from
multiple chronic conditions, functional limitations, behavioral
health problems, socioeconomic challenges, and inadequate
coordination of care [1,2]. Nearly half of all US adults suffer
from a chronic illness and this group accounts for a large share
of health care costs [3]. Advances in mobile phone technology
coupled with increased availability and adoption of mobile
health apps have changed the landscape of self-management
[4]. Data increasingly support the role of patient-facing health
information technology tools in improving patient-centered care
outcomes, health services efficiency, and health outcomes [5-7].
Community health centers and clinics that care for vulnerable
populations overwhelmingly perceive mobile health technologies
as an ideal tool to engage their patient populations in chronic
disease management [8].
Although more than 165,000 mobile health apps are available
on the iTunes (iOS) and Google Play (Android) app stores in
the Unites States [9] and billions of dollars are being invested
in digital health [10], it is not clear how many of these apps
focus on patients with chronic conditions and how well the
scientific evidence supports their effectiveness. Prior reviews
of the literature evaluating the use of patient-facing health apps
have been limited by a narrow scope. Reviews have focused on
a single medical condition [11-13], on a single aspect of a broad
group of apps (such as identifying target populations, behavioral
functionalities, privacy policies, and expert involvement)
[14-17], or have included only clinical trial–based evidence
[9,18], which represents a minority of the ongoing research. A
recent systematic review of apps targeting diabetes mellitus,
cardiovascular disease, and lung disease found only 3 studies
in which a chronic disease management app was used as an
intervention and a clinical outcome was measured [19]. Another
review focused on how apps can be leveraged by
nonprofessional caregivers to care for patients [20].
Although clinical trial evidence supporting the use of apps is
generally lacking, this finding may be explained by several
factors. First, health apps are fairly new as a medium for
engaging patients in comparison with other digital media;
therefore, research supporting their use may be ongoing but not
yet published. If that is the case, evidence may be found in “gray
literature” such as conference proceedings that has not yet made
its way to peer-reviewed journals. Second, app developers may
be participating in and using research findings to market their
apps, which may favor obtaining lower-quality evidence because
it is less costly and potentially biased toward a favorable result.
Third, it is possible that high-quality evidence exists but that
prior reviews failed to uncover it because they focused too
narrowly on a small set of disease areas. Given this set of
limitations, a “scoping review” may better describe the extent
and quality of the literature as well as evidence gaps in
comparison with a traditional systematic review [21].
To address the need for a comprehensive assessment of health
app evidence, we performed a scoping review in order to (1)
assess the breadth of app coverage across HNHC populations,
(2) characterize the quality of the published literature (including
full-length journal articles and work presented at scientific
conferences), (3) evaluate the possibility of biases due to
conflicts of interest, and (4) evaluate the types of outcomes
measured.
Methods
Data Sources and Searches
Studies that evaluated health-related apps for mobile devices
were identified by searching PubMed and MEDLINE (National
Center for Biotechnology Information), EMBASE (Elsevier),
the Cochrane Central Register of Controlled Trials (EBSCO),
Web of Science (including the Conference Proceedings Citation
Indexes; Thomson Reuters), and the NTIS (National Technical
Information Service) Bibliographic Database (EBSCO). The
search was conducted between June 20, 2014, and July 14, 2014.
The complete search strategy including search terms is available
in Multimedia Appendix 1. Our search was designed to identify
studies examining applications or software programs running
on mobile devices such as mobile phones or tablets that are
designed to address the health-related needs of specific HNHC
populations. Populations included in the search were older adults
(age ≥65 years); individuals with chronic conditions including
coronary artery disease, congestive heart failure, hypertension,
stroke, chronic obstructive pulmonary disease, cancer, diabetes
mellitus, obesity, arthritis, chronic kidney disease, cirrhosis,
organ transplantation, or chronic pain; the psychologically or
mentally vulnerable who have been diagnosed with depression,
bipolar disease, posttraumatic stress disorder, attention-deficit
hyperactivity disorder, autism, substance-related disorders,
dementia, cognitive impairment, developmental delays, or
mental impairment; individuals with medication management
issues (multiple medications); individuals with physical
handicaps or disabilities, including the blind and deaf; and the
socially vulnerable including those with low literacy or
numeracy, limited English proficiency, minority status (Native
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American, Hispanic, African American), low income or
homelessness, or infection with human immunodeficiency virus.
Appropriate controlled vocabulary terms were included when
available (Medical Subject Headings and Emtree). The retrieval
set was limited to articles published in 2008 or later; this start
date was selected to coincide with when the iOS and the Android
app stores were established. No language restrictions were
applied, although non-English abstracts were excluded during
title and abstract review (Figure 1). Articles not pertaining to
native iOS and Android apps were excluded during the full
manuscript review.
Figure 1. Article selection process.
Study Selection
All titles and abstracts were individually examined by 2
reviewers (KS and KD, or KS and LPN). Abstracts were
included if they described original research written in the
English language involving use of an iOS- or Android-based
health-related patient-facing mobile app by study subjects.
Patient-facing apps are those intended for use primarily by
patients or their caregivers. We selected articles that described
either iOS or Android apps because the 2 operating systems
serve different demographics, with lower-income individuals,
blacks, and younger adults preferring Android devices [22].
Articles describing apps focused on supportive technologies
(eg, hearing or vision aids), communication technologies (eg,
apps used to help autistic children communicate in school
settings), or apps requiring a medical device (eg, an app to
interact with artificial pancreas) were excluded. Study design
was not a basis for exclusion. Full-length articles were obtained
for all abstracts identified for inclusion by either reviewer.
Certain included abstracts could not be linked to full-length
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manuscripts because they were associated with conference
proceedings, including oral presentations or poster sessions;
these abstracts were included despite the absence of a full-length
manuscript as we wanted to capture gray literature in our review.
The full-length manuscripts and conference abstracts were
evaluated by 2 reviewers (MF and ES) to confirm that they met
the inclusion criteria. Articles identified for inclusion by both
reviewers were selected for abstraction. Articles where the 2
reviewers disagreed were evaluated by a third reviewer (KD)
to break ties.
Data Extraction and Quality Assessment
An abstraction survey tool was created to capture information
about both the mobile app as described in the publication and
the study itself, including the characteristics of the studied apps,
quality of evidence, presence of conflict of interest, and types
of outcomes evaluated. During a pilot phase, 8 study
investigators each abstracted 3 articles using the tool (24 articles
in total); changes were made based on feedback until there was
consensus regarding the face validity of the tool.
Abstraction of the selected articles was then performed by 1
reviewer (MF or ES). A total of 40 randomly selected articles
were evaluated by both reviewers to assess the level of
agreement (Table 1).
Details regarding the abstracted items are presented in
Multimedia Appendix 2. App engagement was assessed using
a previously described framework [23]. We evaluated the
following areas for each article:
General
We captured information about the app studied, including its
target population, platform, availability on the app store, and
functionalities to support patient engagement.
Quality of the Evidence
We ascertained factors that influence quality and generalizability
of the article, including study design, enrollment, follow-up,
role of the app in the context of the intervention, and inclusion
of relevant patient populations.
Declaration of Conflicts
We determined whether any members of the research team were
developers of the app in question (or in a formal role supporting
app development such as the advisory board) or whether the
app developer directly funded the research. While a conflict of
interest does not invalidate the results of a given study, literature
written or funded by a company responsible for the product
being researched is known to be systematically biased [24].
Outcomes Evaluated
We evaluated the outcomes considered by each study and
assessed their direction (ie, positive, neutral, or negative).
Clinical outcomes were those directly related to patient care
(eg, decreased hemoglobin A1c). Safety or adverse event
outcomes were those relevant to unintended negative
consequences of an app. Usability outcomes were those
describing an app’s ease of use—in some usability studies,
multiple rounds of testing are performed, in which case the
direction of the outcome was classified based on the final round
of testing. Usage describes the amount of time users engaged
with the app—this was not reported in a standard fashion and
therefore we based the direction on the authors’ expectations,
considering “sufficient usage” if observed usage matched
expectations. Process outcomes refer to measures pertaining to
actions taken in response to the app (eg, undergoing testing for
hemoglobin A1c)—because the result of the action is not
considered (eg, decreased hemoglobin A1c), this is not a clinical
outcome. A validation outcome was considered present when
an app focused on measurement (eg, an app for assessing hepatic
encephalopathy) was compared with a non–app-based clinical
measure. We evaluated whether the app-based measure
performed differently from a non–app-based clinical measure
(eg, asterixis). If the article also used a gold standard test (eg,
neuropsychiatric testing), we ascertained whether the app-based
measure was better or worse than the non–app-based clinical
measure. The user satisfaction outcome referred simply to
whether users were satisfied with an app.
Data Synthesis and Analysis
Data from the reviewers were imported into R version 3.2.2 (R
Foundation for Statistical Computing). Descriptive statistics
were calculated and accompanied by a narrative summary.
Results
Article Selection and Abstraction
We identified 7301 titles and abstracts, of which 800 were
identified for inclusion by either reviewer (Figure 1). Two
reviewers evaluated the full-length manuscripts and 146 articles
were selected by both reviewers for abstraction. Of the 90
articles identified for inclusion by only 1 reviewer, a third
reviewer selected 37 for abstraction, resulting in a total of 183
articles being selected. During the abstraction process, 8 articles
were identified as not meeting the inclusion criteria. After
examination by a second reviewer, consensus was achieved on
all 8 articles to exclude from the analysis. Thus, in total, 175
articles were abstracted (Multimedia Appendix 3).
Of the 40 articles (22.9%, 40/175) randomly selected for
evaluation by both reviewers, 3 were excluded after further
examination. As a result, 37 articles were abstracted by both
reviewers, and the level of agreement was generally good, with
some exceptions such as patient engagement and whether
caregivers were included as subjects (Table 1).
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.4http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 1. Level of agreement on items on the abstraction form.
KappaQuestiona
General
.79bWho is the primary population(s) that would benefit from the app studied?
1.0bWhich platform(s) is used by the app(s) mentioned in the study?
.85bIs the app(s) studied currently available on the iTunes or Google Play app store?
.26bBased on the app's description in the article, how does it engage patients?
1.0Did the app link to a medical device in the study (eg, glucometer)?
1.0Did the app link to a consumer wearable device in the study?
Quality of evidence
.62bWhat is the study design?
.72How many total subjects are enrolled in this study (including controls for controlled trials)?
.59Is the app studied a standalone intervention (or are there multiple interventions concurrent with app use)?
.54What was the average length of follow-up reported (in months)?
.93Was this associated with a conference proceeding (abstract, poster, presentation, etc)?
1.0Does the study have a clinicaltrials.gov registration number?
.49Was at least one of the above vulnerable populations included as subjects in the study?
.85Does the study include children as subjects (people under 18 years old)?
.79Does the study include people aged 65 or older as subjects?
.29Were caregivers for at least one of the above vulnerable populations included as subjects in the study?
Conflict of interest
.52Did the research team or their employer contribute to the design or development of the app?
.35bWhat is the source of external funding for this study?
Outcomes evaluated
.43Was a clinical outcome considered in this study?
.36If yes, in what direction was the clinical outcome with use of the app?
0cWas a safety or adverse event outcome (caused by the use of the app) considered in the study?
.53Was a usability outcome considered in the study?
.71Was a usage outcome considered in the study?
.61If yes, in what direction was the usage outcome with use of the app?
.41Was a process measure considered in this study?
.39If yes, in what direction was the process measure with use of the app?
.80Was a validation outcome considered in this study?
.69If yes, in what direction was the validation outcome with use of the app?
.84Was user satisfaction considered in this study?
.71If yes, in what direction was the satisfaction outcome with use of the app?
aSee Multimedia Appendix 2 for additional information regarding the questions.
bItems where reviewers could select multiple options. Only perfect agreement was considered agreement in the kappa calculation.
cThere was only 1 article evaluated by 2 reviewers in which 1 reviewer marked safety or adverse event outcome as being present.
Identification of Overlapping Research
Of the 175 selected articles, we found 15 sets of articles that
assessed the same app, in some instances using different study
designs, numbers of participants, or end points. For the purposes
of our analysis, we considered each article as separate. We found
2 articles that evaluated the ActiveLifestyle app [25,26],
AsthmaCare [27,28], EncephalApp [29,30], iMigraine [31,32],
iStepLog [33,34], the Mayo Clinic app [35,36], Multiple
Sclerosis Performance Test [37,38], My Meal Mate [39,40],
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Ready~Steady [41,42], a cognitive stimulation app for alcoholics
[43,44], USMART [45,46], ClinTouch [47,48], and a food
addiction intervention [49,50]. We found 3 articles that evaluated
a mobile application in the Women with Epilepsy: Pregnancy
Outcomes and Deliveries (WEPOD) study [51-53] and 3 that
evaluated the SaGAS 20/10 app [54,55].
Characteristics of the Mobile Apps
Of the 27 vulnerable populations targeted by the literature
search, the groups most commonly targeted by apps included
individuals with obesity, physical handicaps, diabetes, older
age, and dementia or mild cognitive impairment (Table 2).
Table 2. Primary population that would benefit from the app studied.
Number of articles (N=175),
n (%)
Populationa
24 (13.7)Obesity
19 (10.9)Physical handicap or disability (including blindness or deafness)
15 (8.6)Diabetes mellitus
15 (8.6)Older adults
14 (8.0)Dementia or mild cognitive impairment
11 (6.3)Cancer
10 (5.7)Autism spectrum disorder
7 (4.0)Alcohol or drug abuse
7 (4.0)Chronic pain
7 (4.0)Depression
6 (3.4)Coronary artery disease
5 (2.9)Schizophrenia or psychosis
4 (2.3)Arthritis
4 (2.3)Stroke
3 (1.7)Cirrhosis
3 (1.7)Congestive heart failure
3 (1.7)Hypertension
3 (1.7)Posttraumatic stress disorder
2 (1.1)Developmentally delayed or mentally impaired
2 (1.1)HIVb or AIDS
1 (0.6)Attention-deficit hyperactivity disorder
1 (0.6)Bipolar disorder
1 (0.6)Chronic kidney disease
1 (0.6)Low income or poor
1 (0.6)Low literacy or low numeracy
1 (0.6)Posttransplant
1 (0.6)Smoking
38 (21.7)None of the above
aThese are not mutually exclusive categories. Articles may evaluate multiple apps and individual apps may target multiple populations.
bHIV: human immunodeficiency virus.
Of the 175 selected articles, 60.6% (106/175) involved iOS
apps, 32.0% (56/175) involved Android apps, and 7.4% (13/175)
involved both. Reviewers evaluated the availability of these
apps on both the iTunes (iOS) and Google Play (Android) app
stores. Reviewers were unable to search for the app being
studied in 40.0% (70/175) of the articles because the name of
the app was not mentioned. Apps from an additional 29.7%
(52/175) articles were searched and unable to be found on either
app store. Among the articles where an app was found, 66%
(35/53) were found on the iOS app store, 6% (3/53) on the
Android app store, and 28% (15/53) on both. The ways in which
apps engaged patients were assessed based on the functionality
described in the articles (Table 3).
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.6http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 3. How health apps engage patients.
Number of articles (N=175)
n (%)
Type of engagementa
132 (75.4)Records information
64 (36.6)Provides guidance
55 (31.4)Displays a patient’s health information
45 (25.7)Reminds or alerts patients
36 (20.6)Provides educational information
36 (20.6)Enables data sharing with clinician
15 (8.6)Enables data sharing with caregiver
14 (8.0)Engages through social media
10 (5.7)Not enough information to determine
6 (3.4)None of the above
aThese are not mutually exclusive categories. Apps may engage patients in multiple ways.
The most common functionalities were recording information,
providing guidance, and displaying health information, and the
least common were engaging with social media and enabling
communication with family members. A total of 6 (3.4%, 6/175)
articles described apps with the ability to connect with a medical
device and 5 (2.9%, 5/175) described apps able to connect with
a consumer wearable device.
Quality of Evidence
The method of dissemination involved full-text publications for
136 articles and conference proceedings (eg, oral or poster
presentation) for 39 articles. Cross-sectional studies accounted
for 42.9% (75/175) of studies (Table 4). Methodologies with
lower bias were represented as follows: randomized controlled
trials (10.3%, 18/175), nonrandomized controlled trials (2.9%,
5/175), and prospective cohort studies (21.7%, 38/175). The
median number of participants in the studies was 31
(interquartile range, IQR, 11.0-207.2, maximum 11,690). The
median length of follow-up for non–cross-sectional
studies—weighted for the number of participants when articles
involved multiple substudies—was 1.4 months (IQR 0.6-3,
maximum 42.6).
Table 4. Study designs used in abstracted articles.
Number of articles (N=175)
n (%)
Study designa
75 (42.9)Cross-sectional study
38 (21.7)Prospective cohort study
34 (19.4)Qualitative research
22 (12.6)Before-after study
18 (10.3)Randomized controlled trial
5 (2.9)Nonrandomized controlled trial
3 (1.7)Case report or case series
1 (0.6)Randomized trial with no control
1 (0.6)Interrupted time series
1 (0.6)Not enough information to determine
aThese are not mutually exclusive categories. Articles may use multiple study designs or may describe multiple substudies.
Among 26 studies with a control arm, the app was the sole
intervention in 21 (81%, 21/26) articles and just one part of a
multipart intervention in 5 (19%, 5/26) articles. In the remaining
149 articles, all study subjects were exposed to the app. Only
7.4% (13/175) studies were registered on ClinicalTrials.gov.
Of the 137 articles for which a specific population was identified
that may benefit from the app (eg, patients with heart disease),
78.1% (107/137) included members of that particular population
in the study; 13.1% (18/137) of studies focused on screening
or prevention and therefore participants were healthy
individuals; the remaining 8.8% (12/137) of studies did not
include participants from the relevant population.
Of the 175 studies, 38 (21.7%, 38/175) studies included children,
53 (30.3%, 53/175) included adults aged 65 years or older, and
17 (9.7%, 17/175) included caregivers of HNHC patients.
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Declaration of Conflicts
The authors of the 175 identified studies or their employer
directly contributed to the design or development of the app in
107 (61.1%, 107/175) articles; among these, however, 5 (2.9%,
5/175) did not state this explicitly in the body of the paper. The
authors of the identified studies were not involved in app
development in 28 (16.0%, 28/175) articles, and in 40 (22.9%,
40/175) we were unable to confirm the presence or absence of
involvement. Of the 175 studies, 61 (34.9%, 61/175) studies
were funded by a government agency, 41 (23.4%, 41/175) by
a nonprofit organization, 12 (6.9%, 12/175) by a for-profit
company, and 6 (3.4%, 6/175) by a medical professional society;
5 (2.9%, 5/175) studies reported they had no external funding.
No statement about the funding source was present in 82 (46.9%,
82/175) articles.
Types of Outcomes Evaluated
Among the 175 articles, 87 (49.7%, 87/175) articles evaluated
user satisfaction, finding users to be generally satisfied in 74
(85%, 74/87), generally unsatisfied in 2 (2%, 2/87), and neutral
in the remaining 11 (13%, 11/87) articles. A total of 74 (42.3%,
74/175) articles evaluated usability—often multiple cycles of
testing were described, and the first cycle typically had worse
performance than later cycles after modifications were made.
A total of 61 (34.9%, 61/175) articles looked at usage, finding
“sufficient” usage in 53 (87%, 53/61) and lower-than-expected
use in 8 (13%, 8/61). Of the 175 articles, 56 (32.0%, 56/175)
articles validated the measurement ability of apps in comparison
with a clinical measure, finding the app to perform better than
the clinical measure in 6 (11%, 6/56), worse than the clinical
measure in 17 (30%, 17/56), and no different from the clinical
measure in 34 (61%, 34/56) studies. A total of 40 (22.9%,
40/175) studies assessed a process measure (eg, increased
administration of smoking cessation counseling), as opposed
to a clinical outcome (eg, decreased rate of lung cancer). Of
these, there were 35 (88%, 35/40) studies with improvement, 1
(2%, 1/40) with worsening, and 4 (10%, 4/40) with no change
in the process outcome. A total of 36 (20.6%, 36/175) articles
evaluated clinical outcomes, with 26 (72%, 26/36) demonstrating
improvement in clinical outcomes and 10 (28%, 10/36) with no
change. Only 9 (5.1%, 9/175) articles considered a safety or
adverse event outcome caused by use of the app.
Discussion
Principal Findings
While there is optimism that mobile health apps may support
the health of HNHC populations, existing research does not
robustly evaluate this potential. Our review of the evidence
supporting patient-facing mobile health apps identified a number
of gaps in the current body of research. A few HNHC groups
(older adults and people with obesity, physical handicaps,
diabetes, and dementia) are more commonly studied, and we
found less than 10 studies published for 20 of the 27 HNHC
groups included in our review. The majority of apps studied
were unavailable to consumers, the study designs were primarily
cross-sectional, non–cross-sectional studies had a fairly short
length of follow-up, and study sizes were small. In most cases,
developers were often the ones evaluating the apps, sample sizes
were small, funding sources were ambiguous, and clinical
outcomes were evaluated in a minority of studies. Even among
high-quality studies, drawing an inference about the usefulness
of an app was frequently limited by intervention arms in which
the app was a small piece of a much larger intervention.
Some of the methodological problems we identified such as
small sample sizes and short length of follow-up could be
addressed if apps incorporated the consent process and data
collection into the apps’ functionality. Many of the studies used
a traditional “in-person” consent process in order to enroll study
subjects. While this may conform to the standards of traditional
clinical research, using this approach may limit the number of
subjects who can be enrolled and the length of follow-up. New
methodological approaches that enable large-scale app outcomes
research are needed [56]. Controlled trials where the consent
process and data collection occur entirely in the context of a
publicly available app may enable such work. The barrier to
entry for integrating research into apps has been lowered by
frameworks such as Apple ResearchKit, which was used to
enroll 11,000 participants for a cardiovascular study in 24 hours
[57].
Recommendations
On the basis of our findings, we make the following
recommendations for researchers undertaking the study of
mobile apps for the purposes of dissemination:
First, the researchers should consider evaluating apps in
understudied HNHC groups to address the current imbalance
in the body of research between HNHC groups. Second, reports
should include the name of the app or intervention, so that
literature about the app can be linked to it definitively; every
effort should be made to include a bundle ID, permanent app
store weblink, or other unique identifier to facilitate
identification of the app. Third, researchers conducting
interventional studies should consider the inclusion of both a
control arm and an app-only intervention arm to make clearer
the link between the app and the outcome. Fourth, studies should
clearly state the nature of the relationship between the study
contributors and the app developers; if the researchers are also
the app developers, researchers should consider validating their
work at an additional site supervised by a nondeveloper. Fifth,
studies should clearly state the funding source or note if no
external funding was used. Finally, researchers should report
negative results.
In addition, funders will need to support additional evaluations
of apps and should target evaluations that target clinically
important outcomes and are large enough to deliver meaningful
results. With newer enrollment approaches, it may be possible
to enable much larger clinical trials, which may be feasible at
low expense because much of the data usually collected may
be extracted from existing electronic health records.
We used a robust multistage scoping review process involving
2 reviewers in most steps. We included gray literature in our
analysis through a search of conference proceedings and did
not limit our analysis to only high-quality evidence.
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Limitations
Although 2 reviewers participated in the process of screening
abstracts and full-length manuscripts for eligibility, data
abstraction was carried out by only 1 reviewer for most studies.
While the majority (17 of 30) of abstracted items had good
agreement among the reviewers, interrater agreement was
moderate (kappa .41-.6) for 7 items and fair (kappa .21-.40) for
6 questions, which limits the reliability of conclusions drawn
from them. To put the kappa values into context, 2 reviewers
agreed on ascertainment of a clinical outcome (kappa .43) on
31 out of 37 articles. In particular, the questions with the lowest
interrater agreement involved determining whether safety or
adverse event outcomes were considered, whether caregivers
were included the study, how the app mentioned in the study
engaged patients, and the funding source. The low agreement
levels for these questions may be attributed to the heterogeneity
in the detail to which studies reported information about the
apps and study conducted, which is partly due to the inclusion
of conference abstracts in our analysis. The agreement was
moderate when reviewers abstracted the types of outcomes
measured in the studies. We attribute this partly to the breadth
of populations that we considered because what constitutes a
clinical outcome differs significantly between chronic
conditions. Additionally, differentiating clinical outcomes from
process outcomes carries some subjectivity and may introduce
disagreements. We did revise our abstraction form based on a
review of 24 articles during a pilot phase, but additional cycles
of revision may have further improved interrater agreement.
We did not evaluate articles that were not in English, which
limits our generalizability toward apps targeting non-English
speakers. Finally, we conducted our literature search in 2014,
which does not capture recent trends.
Recent Trends in the Literature
Recent studies of patient-facing apps have provided supporting
evidence for the role of apps in several areas. In a 2016
randomized controlled crossover study of a mobile app focused
on supporting drug intake and vital sign documentation,
researchers found that patients who used the iPad app showed
greater adherence for both medication intake and blood pressure
measurement than a paper-based control group [58]. Another
randomized controlled study published in 2016 found that
overweight and obese adults who used a social support app lost
on average 3 kg more than patients using a self-monitoring
control app over the course of the study [59]. Evidence from
other recent trials has demonstrated the ability of apps to reduce
consumption of sugar-sweetened beverages in women and
nutrient-poor foods in men, increase activity level and reduce
fatigue following stroke, and improve respiratory parameters
with a reduction in corticosteroid usage among individuals with
uncontrolled asthma [60-62].
Conclusions
In the future, providers may routinely prescribe apps for their
HNHC patients, and health care systems may invest in them.
However, given the limited availability of high-quality evidence
for most of the HNHC groups included in our review, we would
not expect systematic reviews or meta-analyses focused on these
groups individually to yield enough evidence to assess the
effectiveness of disease-specific apps. Additionally, apps are
being lost in translation from research to the app stores, resulting
in a lack of commercial impact of existing research. Despite
these limitations, the body of evidence overwhelmingly reports
early results that favor the use of mobile health apps.
 
Acknowledgments
We would like to acknowledge the efforts of Shreyas Ramani, a master’s student in health informatics at the University of
Michigan, for providing assistance with revisions of the manuscript. This research was supported by The Commonwealth Fund.
Conflicts of Interest
EP serves as a mentor at Rock Health and previously served as Chief Medical Officer at Twine Health, a mobile health company.
AL currently serves as an advisor to the Hacking Medicine Institute, a nonprofit organization that evaluates digital health apps,
where he also serves as senior editor on the RANKED Health project.
DWB is a coinventor on Patent No. 6029138 held by Brigham and Women’s Hospital on the use of decision support software
for medical management, licensed to the Medicalis Corporation. He holds a minority equity position in the privately held company
Medicalis, which develops Web-based decision support for radiology test ordering. He serves on the board for SEA Medical
Systems, which makes intravenous pump technology. He is on the clinical advisory board for Zynx, Inc, which develops
evidence-based algorithms. He consults for EarlySense, which makes patient safety monitoring systems. He receives equity and
cash compensation from QPID, Inc, a company focused on intelligence systems for electronic health records. He receives cash
compensation from CDI (Negev), Ltd, which is a not-for-profit incubator for health information technology start-ups. He receives
equity from Enelgy, which makes software to support evidence-based clinical decisions. He receives equity from Ethosmart,
which makes mobile apps to help patients with chronic diseases. He receives equity from Intensix, which makes software to
support clinical decision making in intensive care. He receives equity from MDClone, which takes clinical data and produces
deidentified versions of the data. DWB’s financial interests have been reviewed by Brigham and Women’s Hospital and Partners
HealthCare in accordance with their institutional policies.
The views presented here are those of the authors and not necessarily those of The Commonwealth Fund or its directors, officers,
or staff. The Commonwealth Fund was not involved in any of the following: design or conduct of the study; collection, management,
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.9http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript
for publication.
Multimedia Appendix 1
Search Terms.
[PDF File (Adobe PDF File), 37KB - mhealth_v4i4e136_app1.pdf ]
Multimedia Appendix 2
Abstraction Form.
[PDF File (Adobe PDF File), 56KB - mhealth_v4i4e136_app2.pdf ]
Multimedia Appendix 3
Articles included in review (n=175) and complete results of abstraction.
[XLSX File (Microsoft Excel File), 60KB - mhealth_v4i4e136_app3.xlsx ]
References
1. Hong CS, Siegel AL, Ferris TG. Caring for high-need, high-cost patients: what makes for a successful care management
program? Issue Brief (Commonw Fund) 2014 Aug;19:1-19. [Medline: 25115035]
2. McCarthy D, Ryan J, Klein S. Models of care for high-need, high-cost patients: an evidence synthesis. Issue Brief (Commonw
Fund) 2015 Oct;31:1-19. [Medline: 26591906]
3. Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 2014
Apr 17;11:E62 [FREE Full text] [doi: 10.5888/pcd11.130389] [Medline: 24742395]
4. Pew Research Center. 2014. Cell Phone and Smartphone Ownership Demographics URL: http://www.pewinternet.org/
data-trend/mobile/cell-phone-and-smartphone-ownership-demographics [accessed 2016-12-07] [WebCite Cache ID
6maR4Vf0h]
5. Greene J, Hibbard JH, Sacks R, Overton V, Parrotta CD. When patient activation levels change, health outcomes and costs
change, too. Health Aff (Millwood) 2015 Mar;34(3):431-437. [doi: 10.1377/hlthaff.2014.0452] [Medline: 25732493]
6. Grando MA, Rozenblum R, Bates DW, editors. Information Technology for Patient Empowerment in Healthcare. 1st ed.
Berlin: Walter de Gruyter Inc; 2015.
7. Hibbard JH, Greene J, Overton V. Patients with lower activation associated with higher costs; delivery systems should
know their patients' 'scores'. Health Aff (Millwood) 2013 Feb;32(2):216-222 [FREE Full text] [doi: 10.1377/hlthaff.2012.1064]
[Medline: 23381513]
8. Broderick A, Haque F. Mobile health and patient engagement in the safety net: a survey of community health centers and
clinics. Issue Brief (Commonw Fund) 2015 May;9:1-9. [Medline: 26040018]
9. IMSHealth. 2015. Patient Adoption of mHealth URL: http://www.imshealth.com/files/web/IMSH%20Institute/Reports/
Patient%20Adoption%20of%20mHealth/IIHI_Patient_Adoption_of_mHealth.pdf [accessed 2016-12-07] [WebCite Cache
ID 6maRVuzDh]
10. Mercurynews. Apple, Google, VCs invest in health technology URL: http://www.mercurynews.com/2014/08/13/
apple-google-vcs-invest-in-health-technology/ [accessed 2016-12-07] [WebCite Cache ID 6maRbIZCz]
11. Martínez-Pérez B, de la Torre-Díez I, López-Coronado M, Herreros-González J. Mobile apps in cardiology: review. JMIR
Mhealth Uhealth 2013 Jul;1(2):e15 [FREE Full text] [doi: 10.2196/mhealth.2737] [Medline: 25098320]
12. Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature
and analysis of current applications compared against evidence-based guidelines. J Med Internet Res 2011 Sep;13(3):e65
[FREE Full text] [doi: 10.2196/jmir.1874] [Medline: 21979293]
13. Wesley KM, Fizur PJ. A review of mobile applications to help adolescent and young adult cancer patients. Adolesc Health
Med Ther 2015 Aug;6:141-148 [FREE Full text] [doi: 10.2147/AHMT.S69209] [Medline: 26316835]
14. Martínez-Pérez B, de la Torre-Díez I, López-Coronado M. Mobile health applications for the most prevalent conditions by
the World Health Organization: review and analysis. J Med Internet Res 2013 Jun 14;15(6):e120 [FREE Full text] [doi:
10.2196/jmir.2600] [Medline: 23770578]
15. Payne HE, Lister C, West JH, Bernhardt JM. Behavioral functionality of mobile apps in health interventions: a systematic
review of the literature. JMIR Mhealth Uhealth 2015 Feb;3(1):e20 [FREE Full text] [doi: 10.2196/mhealth.3335] [Medline:
25803705]
16. Sunyaev A, Dehling T, Taylor PL, Mandl KD. Availability and quality of mobile health app privacy policies. J Am Med
Inform Assoc 2015 Apr;22(e1):e28-e33 [FREE Full text] [doi: 10.1136/amiajnl-2013-002605] [Medline: 25147247]
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.10http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
17. Subhi Y, Bube SH, Rolskov Bojsen S, Skou Thomsen AS, Konge L. Expert involvement and adherence to medical evidence
in medical mobile phone apps: a systematic review. JMIR Mhealth Uhealth 2015 Jul;3(3):e79 [FREE Full text] [doi:
10.2196/mhealth.4169] [Medline: 26215371]
18. IMSHealth. Patient Apps for Improved Healthcare: From Novelty to Mainstream URL: http://www.imshealth.com/en/
thought-leadership/quintilesims-institute/reports/patient-apps-for-improved-healthcare [accessed 2016-12-07] [WebCite
Cache ID 6maRqxy4S]
19. Whitehead L, Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition
management: a systematic review. J Med Internet Res 2016 May;18(5):e97 [FREE Full text] [doi: 10.2196/jmir.4883]
[Medline: 27185295]
20. Dyer DE, Kansagara D, McInnes DK, Freeman M, Woods S. Mobile applications and Internet-based approaches for
supporting non-professional caregivers: a systematic review. Department of Veterans Affairs (US) 2012 Nov. [Medline:
23285508]
21. Armstrong R, Hall BJ, Doyle J, Waters E. Cochrane Update. 'Scoping the scope' of a cochrane review. J Public Health
(Oxf) 2011 Mar;33(1):147-150 [FREE Full text] [doi: 10.1093/pubmed/fdr015] [Medline: 21345890]
22. Pew Research Center. Smartphone Ownership 2013 URL: http://www.pewinternet.org/2013/06/05/
smartphone-ownership-2013/ [accessed 2016-12-07] [WebCite Cache ID 6maS8HFss]
23. Singh K, Drouin K, Newmark LP, Rozenblum R, Lee J, Landman A, et al. Developing a framework for evaluating the
patient engagement, quality, and safety of mobile health applications. Issue Brief (Commonw Fund) 2016 Feb;5:1-11.
[Medline: 26934758]
24. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality:
systematic review. Br Med J 2003 May 31;326(7400):1167-1170 [FREE Full text] [doi: 10.1136/bmj.326.7400.1167]
[Medline: 12775614]
25. Silveira P, van het Reve E, Daniel F, Casati F, de Bruin ED. Motivating and assisting physical exercise in independently
living older adults: a pilot study. Int J Med Inform 2013 May;82(5):325-334. [doi: 10.1016/j.ijmedinf.2012.11.015] [Medline:
23273420]
26. Silveira P, van de Langenberg R, van Het Reve E, Daniel F, Casati F, de Bruin ED. Tablet-based strength-balance training
to motivate and improve adherence to exercise in independently living older people: a phase II preclinical exploratory trial.
J Med Internet Res 2013 Aug 12;15(8):e159 [FREE Full text] [doi: 10.2196/jmir.2579] [Medline: 23939401]
27. Farooqui N, Phillips G, Stukus DR. Feasibility and acceptability of a novel asthma self-management smartphone application
for children and adolescents. J Allergy Clin Immunol 2014 Feb;133(2):AB127. [doi: 10.1016/j.jaci.2013.12.473]
28. Stukus DR, Phillips G, Farooqui N. Improved education and self-management in children and adolescents with asthma
using a personalized smartphone application. J Allergy Clin Immunol 2014 Feb;133(2):AB156. [doi:
10.1016/j.jaci.2013.12.568]
29. Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, et al. The Stroop smartphone application is a short
and valid method to screen for minimal hepatic encephalopathy. Hepatology 2013 Sep;58(3):1122-1132 [FREE Full text]
[doi: 10.1002/hep.26309] [Medline: 23389962]
30. Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S, et al. Validation of encephalApp, smartphone-based
stroop test, for the diagnosis of covert hepatic encephalopathy. Clin Gastroenterol Hepatol 2015 Oct;13(10):1828-1835.e1
[FREE Full text] [doi: 10.1016/j.cgh.2014.05.011] [Medline: 24846278]
31. Nelson TD, Aylward BS, Peugh J, Kroner J, Sullivan S, Hershey AD, et al. Variability in adolescent migraine symptoms
and correlates of individual symptom variability. 2013 Presented at: 2013 International Headache Congress; June 27-30,
2013; Boston, MA p. 186.
32. Sullivan S, Kroner J, Aylward B, Allen JR, Kabbouche M, O'Brien H, et al. A mobile application to track pain and functioning
in adolescents: feasibility and initial results. 2015 Presented at: 54th American Headache Society Annual Meeting; June
21-24, 2012; Los Angeles, CA p. 897.
33. Kirwan M, Duncan MJ, Vandelanotte C, Mummery WK. Design, development, and formative evaluation of a smartphone
application for recording and monitoring physical activity levels: the 10,000 Steps “iStepLog”. Health Educ Behav 2013
Apr;40(2):140-151. [doi: 10.1177/1090198112449460] [Medline: 22984196]
34. Kirwan M, Duncan MJ, Vandelanotte C, Mummery WK. Using smartphone technology to monitor physical activity in the
10,000 Steps program: a matched case-control trial. J Med Internet Res 2012 Apr 20;14(2):e55 [FREE Full text] [doi:
10.2196/jmir.1950] [Medline: 22522112]
35. Cook DJ, Manning DM, Holland DE, Prinsen SK, Rudzik SD, Roger VL, et al. Patient engagement and reported outcomes
in surgical recovery: effectiveness of an e-health platform. J Am Coll Surg 2013 Oct;217(4):648-655. [doi:
10.1016/j.jamcollsurg.2013.05.003] [Medline: 23891066]
36. Cook DJ, Moradkhani A, Douglas KSV, Prinsen SK, Fischer EN, Schroeder DR. Patient education self-management during
surgical recovery: combining mobile (iPad) and a content management system. Telemed J E Health 2014 Apr;20(4):312-317
[FREE Full text] [doi: 10.1089/tmj.2013.0219] [Medline: 24443928]
37. Miller D, Lee J, Bethoux F, Rao S, Alberts J, Schindler D, et al. Multiple sclerosis performance test: patients express high
satisfaction with the application. Neurology 2014 Apr 8;82(10 Supplement P3.140).
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.11http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
38. Rudick RA, Miller D, Bethoux F, Rao SM, Lee J, Stough D, et al. The multiple sclerosis performance test (MSPT): an
iPad-based disability assessment tool. J Vis Exp 2014 Jun 30(88):e51318 [FREE Full text] [doi: 10.3791/51318] [Medline:
25046650]
39. Carter MC, Burley VJ, Nykjaer C, Cade JE. Adherence to a smartphone application for weight loss compared to website
and paper diary: pilot randomized controlled trial. J Med Internet Res 2013 Apr;15(4):e32 [FREE Full text] [doi:
10.2196/jmir.2283] [Medline: 23587561]
40. Carter MC, Burley VJ, Nykjaer C, Cade JE. 'My Meal Mate' (MMM): validation of the diet measures captured on a
smartphone application to facilitate weight loss. Br J Nutr 2013 Feb 14;109(3):539-546. [doi: 10.1017/S0007114512001353]
[Medline: 22717334]
41. Vankipuram M, McMahon S, Fleury J. ReadySteady: app for accelerometer-based activity monitoring and wellness-motivation
feedback system for older adults. 2012 Presented at: AMIA Annual Symposium; November 3, 2012 - November 7, 2012;
Chicago, IL.
42. McMahon S, Vankipuram M, Hekler EB, Fleury J. Design and evaluation of theory-informed technology to augment a
wellness motivation intervention. Transl Behav Med 2014 Mar;4(1):95-107 [FREE Full text] [doi:
10.1007/s13142-013-0221-4] [Medline: 24653780]
43. Gamito P, Oliveira J, Lopes P, Morais D, Brito R, Saraiva T, et al. Assessment of frontal brain functions in alcoholics
following a health mobile cognitive stimulation approach. Stud Health Technol Inform 2013;191:110-114. [Medline:
23792854]
44. Gamito P, Oliveira J, Lopes P, Brito R, Morais D, Silva D, et al. Executive functioning in alcoholics following an mHealth
cognitive stimulation program: randomized controlled trial. J Med Internet Res 2014 Apr 17;16(4):e102 [FREE Full text]
[doi: 10.2196/jmir.2923] [Medline: 24742381]
45. Han JW, Oh K, Kim T, Chi Y, Kim K. Spaced retrieval training in mild cognitive impairment and early alzheimer's disease.
Int Psychogeriatr 2013;25:S12-S13.
46. Han JW, Oh K, Yoo S, Kim E, Ahn K, Son Y, et al. Development of the ubiquitous spaced retrieval-based memory
advancement and rehabilitation training program. Psychiatry Investig 2014 Jan;11(1):52-58 [FREE Full text] [doi:
10.4306/pi.2014.11.1.52] [Medline: 24605124]
47. Palmier-Claus JE, Ainsworth J, Machin M, Barrowclough C, Dunn G, Barkus E, et al. The feasibility and validity of
ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry 2012 Oct 17;12:172
[FREE Full text] [doi: 10.1186/1471-244X-12-172] [Medline: 23075387]
48. Palmier-Claus JE, Rogers A, Ainsworth J, Machin M, Barrowclough C, Laverty L, et al. Integrating mobile-phone based
assessment for psychosis into people's everyday lives and clinical care: a qualitative study. BMC Psychiatry 2013 Jan
23;13:34 [FREE Full text] [doi: 10.1186/1471-244X-13-34] [Medline: 23343329]
49. Pretlow R. Substance dependence (problem food) approach to childhood obesity, implemented as a smartphone APP: a
pilot study. Obes Facts 2012;5:195.
50. Pretlow R. Addiction model intervention for obesity, implemented as a smartphone App: A pilot study. J Behav Addict
2013;2:29.
51. Ernst L, Llewellyn N, French J, Pennell PB, Bartfield E, Lau C, et al. Medication adherence in WWE via use of IPOD
application tracking device. Epilepsia 2013;54:131.
52. Llewellyn NG, Harden CL, French J, Pennell PB, Bartfeld E, Davis AR, et al. Maintenance of subject adherence to daily
diary entry facilitated by use of a mobile application in the WEPOD study. Epilepsy Curr 2013;13:69-70.
53. Pennell P, French J, Harden CL. Evaluation of a mobile application tool in the wepod study. Epilepsy Curr 2012;12(1).
54. Zeber AC, Vaney C, Vaney S. Displaying the motor components of the MSFC as an interval score on an iPhone App with
SaGAS 20/10. Clin Neurophysiol 2012;123(10):e113-e114.
55. Vaney C, Forkel N, Hilfiker R. Validity and responsiveness of SaGAS 20/10, a revised and simplified version of SaGAS
(Short and Graphic Ability Score) in the rehabilitation of patients with neurological diseases. Mult Scler 2013;19(11):121-122.
56. Powell AC, Landman AB, Bates DW. In search of a few good apps. J Am Med Assoc 2014 May 14;311(18):1851-1852.
[doi: 10.1001/jama.2014.2564] [Medline: 24664278]
57. Rosa C, Campbell AN, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemp Clin Trials
2015 Nov;45(Pt A):41-54. [doi: 10.1016/j.cct.2015.07.007] [Medline: 26176884]
58. Mertens A, Brandl C, Miron-Shatz T, Schlick C, Neumann T, Kribben A, et al. A mobile application improves
therapy-adherence rates in elderly patients undergoing rehabilitation: a crossover design study comparing documentation
via iPad with paper-based control. Medicine (Baltimore) 2016 Sep;95(36):e4446 [FREE Full text] [doi:
10.1097/MD.0000000000004446] [Medline: 27603339]
59. Hales S, Turner-McGrievy GM, Wilcox S, Fahim A, Davis RE, Huhns M, et al. Social networks for improving healthy
weight loss behaviors for overweight and obese adults: a randomized clinical trial of the social pounds off digitally (Social
POD) mobile app. Int J Med Inform 2016 Oct;94:81-90. [doi: 10.1016/j.ijmedinf.2016.07.003] [Medline: 27573315]
60. Kerr DA, Harray AJ, Pollard CM, Dhaliwal SS, Delp EJ, Howat PA, et al. The connecting health and technology study: a
6-month randomized controlled trial to improve nutrition behaviours using a mobile food record and text messaging support
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.12http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
in young adults. Int J Behav Nutr Phys Act 2016 Apr 21;13:52 [FREE Full text] [doi: 10.1186/s12966-016-0376-8] [Medline:
27098449]
61. Paul L, Wyke S, Brewster S, Sattar N, Gill JM, Alexander G, et al. Increasing physical activity in stroke survivors using
STARFISH, an interactive mobile phone application: a pilot study. Top Stroke Rehabil 2016 Jun;23(3):170-177. [doi:
10.1080/10749357.2015.1122266] [Medline: 27077973]
62. Cook KA, Modena BD, Simon RA. Improvement in asthma control using a minimally burdensome and proactive smartphone
application. J Allergy Clin Immunol Pract 2016 Jul;4(4):730-737.e1. [doi: 10.1016/j.jaip.2016.03.005] [Medline: 27107690]
Abbreviations
HNHC: high-need, high-cost
IQR: interquartile range
Edited by G Eysenbach; submitted 04.08.16; peer-reviewed by YC Li, L Laranjo, F Seidl, S Woods, C Short, F Ehrler, H MacLeod;
comments to author 14.09.16; revised version received 01.11.16; accepted 23.11.16; published 19.12.16
Please cite as:
Singh K, Drouin K, Newmark LP, Filkins M, Silvers E, Bain PA, Zulman DM, Lee JH, Rozenblum R, Pabo E, Landman A, Klinger
EV, Bates DW
Patient-Facing Mobile Apps to Treat High-Need, High-Cost Populations: A Scoping Review
JMIR Mhealth Uhealth 2016;4(4):e136
URL: http://mhealth.jmir.org/2016/4/e136/ 
doi:10.2196/mhealth.6445
PMID:27993761
©Karandeep Singh, Kaitlin Drouin, Lisa P Newmark, Malina Filkins, Elizabeth Silvers, Paul A Bain, Donna M Zulman, Jae-Ho
Lee, Ronen Rozenblum, Erika Pabo, Adam Landman, Elissa V Klinger, David W Bates. Originally published in JMIR Mhealth
and Uhealth (http://mhealth.jmir.org), 19.12.2016. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The
complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and
license information must be included.
JMIR Mhealth Uhealth 2016 | vol. 4 | iss. 4 | e136 | p.13http://mhealth.jmir.org/2016/4/e136/
(page number not for citation purposes)
Singh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
